Literature DB >> 20061783

A new radioguided procedure for localization and surgical treatment of neck node metastasis of papillary thyroid cancer.

A Martino1, L Monaco, R Golia, P Miletto, P Capasso, C Lombardi, G De Chiara, C Iannace, C Basagni, F Caracciolo.   

Abstract

AIM OF THE STUDY: We intended to use a radioguided technique for pre-operative localization of neck node recurrences in patients with papillary thyroid cancer (PTC) already submitted to thyroidectomy and radioiodine treatment. PATIENTS AND METHODS: We selected 20 patients affected by PTC with evidence of neck nodes recurrences at ultrasound examination. Our method has been derived from the Radioguided Occult Lesion Localization technique used for pre-operative localization of occult breast lesions. The technique involves the inoculation of human albumin macroaggregates labeled with radioactive technetium (0.4 mCi in a volume of 0.05 ml) directly in the suspicious lesion, under ultrasound guidance. The persistence of the radioactive tracer in the nodes is confirmed by a scintigraphy performed 2 h after injection. During surgery, a gamma detecting probe is used to locate the suspicious lesions as "hot spots".
RESULTS: Fifty lymph-nodes were injected with the tracer. All radiolabeled lymph-nodes were located and removed during surgery. At histology, metastasis of PTC was confirmed in 38/50 (76%) lymph-nodes. At least one metastatic lymph-node per patient was removed. In 8/20 (40%) patients, reactive lymphoid hyperplasia was found in 12/50 (24%) lymph-nodes.
CONCLUSIONS: This radioguided technique has been highly effective for localization and surgical treatment of suspicious lymph-node detected at neck ultrasound and may play a valuable role in case of node metastases of thyroid cancer that show no radioiodine uptake.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20061783     DOI: 10.1007/BF03346596

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

Review 1.  Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; R T Kloos
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

2.  Radioguided occult lesion localization (ROLL) in breast cancer: maximizing efficacy, minimizing mutilation.

Authors:  G Paganelli; A Luini; U Veronesi
Journal:  Ann Oncol       Date:  2002-12       Impact factor: 32.976

3.  Combined radioguided nonpalpable lesion localization and sentinel lymph node biopsy for early breast carcinoma.

Authors:  Alfredo C S D Barros; Maria A C Barros; Felipe E Andrade; Lincon J Mori; Paulo A Costa; Peng Y Sheng; Christina H T Pelizon
Journal:  Ann Surg Oncol       Date:  2007-01-17       Impact factor: 5.344

4.  Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer.

Authors:  Sophie Leboulleux; Elizabeth Girard; Mathieu Rose; Jean Paul Travagli; Nadia Sabbah; Bernard Caillou; Dana M Hartl; Nathalie Lassau; Eric Baudin; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2007-07-03       Impact factor: 5.958

5.  Radioguided surgery of occult breast lesions.

Authors:  A Luini; S Zurrida; V Galimberti; G Paganelli
Journal:  Eur J Cancer       Date:  1998-01       Impact factor: 9.162

6.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

7.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

8.  Combined radioguided occult lesion and sentinel node localization for breast cancer.

Authors:  Joon Kim; David Chung; Andrew Spillane
Journal:  ANZ J Surg       Date:  2004-07       Impact factor: 1.872

9.  Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspects.

Authors:  C De Cicco; M Pizzamiglio; G Trifirò; A Luini; M Ferrari; G Prisco; V Galimberti; E Cassano; G Viale; M Intra; P Veronesi; G Paganelli
Journal:  Q J Nucl Med       Date:  2002-06

10.  The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients.

Authors:  N A Samaan; P N Schultz; R C Hickey; H Goepfert; T P Haynie; D A Johnston; N G Ordonez
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

View more
  2 in total

1.  Radioguided occult lesion localization for locally recurrent thyroid carcinoma.

Authors:  Mehmet Ali Gulcelik; Niyazi Karaman; Lutfi Dogan; Ilgın Sahiner; Gokhan Giray Akgul; Yavuz Selim Kahraman; Gulin Ucmak Vural
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-13       Impact factor: 2.503

2.  Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma.

Authors:  Tamás Györke; Attila Kollár; Gyula Bottlik; Ágota Szepesi; Imre Bodó; Tamás Masszi; Viktor Bérczi; Ildikó Garai
Journal:  Int J Hematol       Date:  2011-03-01       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.